GLP-1 receptor agonists in patients with cancer are associated with reduced all-cause mortality and hospitalization

Journal:

Journal of Clinical Endocrinology & Metabolism

Published:

2026-01-02

DOI:

10.1210/clinem/dgaf703

Affiliations:

8

Authors:

7

Go to article

Institutions	Authors	Share
University of California, San Francisco (UCSF), United States of America (USA)	3.000000	0.43
Michigan Medicine, U-M, United States of America (USA)	1.000000	0.14
University of California, Irvine (UCI), United States of America (USA)	1.000000	0.14
University of Kentucky (UK), United States of America (USA)	1.000000	0.14
University of California, Davis (UC Davis), United States of America (USA)	1.000000	0.14

Interested in Pharmacology and Pharmaceutical Sciences?